# Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

> clinical trial · VERIFIED · 2026-07-13

Status: ENROLLING_BY_INVITATION · Sponsor: Tianjin Medical University Cancer Institute and Hospital · Condition: PDAC - Pancreatic Ductal Adenocarcinoma

- Company: Tianjin Medical University Cancer Institute and Hospital
- Sector: PDAC - Pancreatic Ductal Adenocarcinoma
- Primary source: https://clinicaltrials.gov/study/NCT05947825

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.